| Shareholder | |||
|---|---|---|---|
| 吴豫生Executive Director | 32.89% | 125.04M | |
| ZHU Julia Ming | 32.88% | 123.47M | |
| 鄭州泰基鴻諾醫藥股份有限公司 | 26.63% | 100.00M | |
| 北京厚紀景橋創業投資有限公司 | 5.30% | 19.40M | |
| 北京融辰厚紀投資管理有限公司 | 5.30% | 19.40M | |
| 何超Non-Executive Director | 5.10% | 19.40M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| Anchor International Limited | 63.22M | -- | Ceased to be notifiable | 0 | 0.00% | ||
| Anchor International Limited | 63.22M | 7.30 | Other event | 63.22M | 16.63% |
This page shows the major shareholders of TYK MEDICINES-B (02410) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

